Ste-Foy, Canada

Paul Brassard

This inventor holds 1 USPTO granted patent. Top assignee: Universitè Laval. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Brassard. Retrieved from https://idiyas.com/inventor/paul-brassard-0f8ql6rh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Paul Brassard

Introduction

Inventor Paul Brassard, based in Ste-Foy, Canada, has made significant strides in the field of analytical chemistry. With one patent to his name, he has developed innovative compounds that enhance the sensitivity of analytical assays.

Latest Patents

Paul Brassard's notable patent, titled "Luminescent cyclic hydrazides for analytical assays," focuses on derivatives of 5-(lower alkyl)-7-amino-2,3-dihydro-1,4-phthalazinedione. These compounds possess unique luminescent properties, making them valuable tools in clinical chemistry. The derivatives are engineered to provide exceptional sensitivity in luminescent immunoassays, which can transform the capabilities of clinical diagnostics.

Career Highlights

Paul Brassard currently works at Université Laval, a prominent institution in Canada known for its dedication to research and innovation. His work has contributed to advancements in the development of analytical tools that are pivotal for clinical applications.

Collaborations

Throughout his career, Paul has collaborated with fellow researcher Alain Belanger. Their joint efforts have fostered an environment of innovation and propelled advancements in their respective fields.

Conclusion

With his focused research and inventive spirit, Paul Brassard stands out as a noteworthy inventor in the realm of analytical chemistry. His patent significantly enhances the landscape of clinical assays, offering tools that promise to improve diagnostic accuracy and sensitivity in medical testing.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…